Repligen Corp. (RGEN)

162.02 +0.33 (+0.20%) USD  |  NASDAQ  |  Jan 16, 16:00
162.09 +0.07 (+0.04%) Pre-Market: 20:00
More

Repligen Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Enovis Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade